Friday, November 13, 2026

Federal Reserve Eyes Rate Cuts in 2026 as Inflation Moderates, Goolsbee Says

The Federal Reserve is preparing for potential interest rate reductions in 2026 if inflation continues declining, Chicago Fed President Alan Goolsbee indicated. The shift comes as the US economy remains solid with stable labor markets, while equity markets rally on the dovish signals. Enhanced supervision frameworks suggest the Fed is pairing monetary easing with stricter prudential oversight.

From our archive, published before source-traceability. How we work

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
Federal Reserve Eyes Rate Cuts in 2026 as Inflation Moderates, Goolsbee Says
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The Federal Reserve may cut interest rates multiple times in 2026 if inflation continues its downward trajectory, Chicago Fed President Alan Goolsbee said this week. "Interest rates can come down more this year if inflation does," Goolsbee stated, pointing to stable economic fundamentals as the backdrop for potential easing.

The US economy has maintained solid growth with stable job markets, creating conditions for the Fed to pivot from its restrictive stance. Equity markets responded positively to the dovish signals, with major indices posting gains as investors priced in lower borrowing costs ahead.

For banks, the rate-cut roadmap presents a margin compression challenge. Net interest income typically narrows as the spread between deposit costs and loan yields shrinks. Regional banks with heavy commercial real estate exposure face additional pressure as lower rates may signal economic caution despite current stability.

Investment strategies are shifting accordingly. Bond portfolios stand to benefit from duration exposure as rate cuts drive yields lower and prices higher. Fixed-income allocations in the 5-10 year maturity range offer optimal positioning for the anticipated easing cycle.

Fintech firms may see improved conditions for growth financing. Lower rates reduce the cost of capital for expansion, particularly for payment processors and lending platforms that have faced tighter funding since 2022. Contactless payment volumes in Finland rose 23% year-over-year to EUR 8.4 billion in Q2 2025, illustrating the sector's momentum heading into the easing cycle.

The Fed is simultaneously tightening supervision frameworks, including enhanced climate risk assessments. This dual approach aims to prevent excessive risk-taking as monetary conditions loosen. Banks must balance opportunities from increased loan demand against stricter capital and liquidity requirements.

The timing and magnitude of cuts remain data-dependent. Core PCE inflation and employment figures will determine whether the Fed delivers the multiple cuts markets anticipate or takes a more gradual approach. Current consensus expects 2-3 cuts totaling 50-75 basis points through year-end.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score4 source documents4 with a live linkVerifiability: Strong
  1. [1]Press releaseGlobeNewswire· February 27, 2026
    Finland Prepaid Card and Digital Wallet Market Intelligence Report 2026-2030: Edenred and ePassi Compete on App-Led Usability While Enfuce Strengthens Modular Card Issuing
  2. [2]News articleNasdaq· February 26, 2026
    Stocks Finish Mostly Lower as Nvidia Weighs on Chipmakers
  3. [3]News articleNasdaq· February 21, 2026
    Stocks Settle Higher as SCOTUS Rejects President Trump’s Tariffs
  4. [4]News articleYahoo Finance· December 12, 2025
    XRP Plans Zero-Knowledge Privacy Layer: Can Privacy Adoption Drive Price to $6?

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com